Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
8 May 2017 |
Main ID: |
ISRCTN84990302 |
Date of registration:
|
12/05/2010 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Cortisol reactivity as a biomarker for depression
|
Scientific title:
|
Cortisol hyper-reactivity to stress - a putative biomarker for major depressive disorder |
Date of first enrolment:
|
13/04/2010 |
Target sample size:
|
228 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN84990302 |
Study type:
|
Observational |
Study design:
|
Single-centre screening clinical laboratory study (Screening)
|
Phase:
|
Not Applicable
|
|
Countries of recruitment
|
United Kingdom
| | | | | | | |
Contacts
|
Name:
|
Paul
Wilkinson |
Address:
|
Developmental Psychiatry Section
University of Cambridge
Douglas House
18b Trumpington Road
CB2 8AH
Cambridge
United Kingdom |
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Aged 16 - 21 years old 2. Male and female 3. Recruited from Roots study
Exclusion criteria: 1. Take regular steroid medication (oral or inhaled) or take hormonal contraceptives containing oestrogens (combined pill, injection, implant or patch) 2. Hypertension requiring regular treatment 3. Systolic blood pressure above 140 mmHg or resting pulse over 100 mmHg at the start of the study 4. Current respiratory disease, e.g., asthma 5. A personal or family history (parent or sibling) of panic disorder 6. Significant claustrophobia 7. Smoke daily; no smoking on day of assessment 8. Migraine within the last year 9. Current heart disease 10. Females will be excluded if they are or think they might be pregnant, are lactating, or their menstrual cycle has not returned to being regular after pregnancy 11. At least one biological grandparent known to be non-white European 12. At least one of the following psychiatric disorders at time of interview: anxiety disorder, OCD, oppositional defiant disorder, PTSD, conduct disorder, bipolar disorder 13. Alcohol or illicit drug use on the day of or the day before research assessment 14. Caffeine use since breakfast on the day of research assessment 15. Consume large amounts of caffeinated drinks on a regular basis (greater than six cups of coffee per day or drinks containing methylxanthines such as Pepsi or red bull) 16. Current severe cold or flu 17. Vigorous exercise for 2 hours before testing
Additional group-specific criteria: 18. Never-depressed participants: 18.1. No lifetime history of major depressive disorder 18.2. No lifetime history of at least one of the following psychiatric disorders: anxiety disorder, OCD, oppositional defiant disorder, PTSD, conduct disorder, bipolar disorder, ADHD 19. Recovered-depressed: 19.1. At least one past episode of major depressive disorder 19.2. At least 8 weeks of having fewer than two depressive symptoms since last episode 19.3. Not currently taking antidepressants 19.4. No lifetime history of ADHD, autism, conduct disorder with onset before age 11
Age minimum:
Age maximum:
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Topic: Mental Health Research Network; Subtopic: Depression, Stress-related and somatoform; Disease: Depression, Stress-related and somatoform disorders Mental and Behavioural Disorders Depressive episode
|
Intervention(s)
|
35% Carbon Dioxide Vital Capacity Inhalation Stress Test: Participants insert the mouthpiece into their mouth. The three-way valve is set so they are breathing air. The experimenter asks the participant to breathe fully out, then take a breath as deep as they can, and hold it for 4 seconds, as a practice. The valve is changed so the CO2 tank is connected to the bag reservoir. The reservoir is filled. The valve is changed so the mouthpiece is attached to the CO2 in the reservoir. The participant breathes in and holds as with the practice.
Trier Social Stress Test: The experimenter leads the participant to the experimental room at time 0, where they are introduced to two people (the 'committee'), a microphone and a video-camera. The experimenter tells the participant that they will have to deliver a speech for a job application to the committee, followed by another task, that will be detailed then. They are given instructions by the committee, then prepare their speech until T +3 min. They are asked to deliver the speech. If they stop before 5 minutes, or their speech is not relevant, there are standard questions and prompts. Then they are asked to do the second task, where they must serially subtract 13 from 1022 as quickly and accurately as possible. After mistakes, they are asked return to 1022 and re-start. This lasts 5 minutes, then the task ends.
Each test happens once, and follow-up is for 60 minutes after start of test.
|
Primary Outcome(s)
|
Salivary cortisol area under the curve in the time period after intervention, collected 20 minutes before and immediately before, and 20, 30, 40 and 60 minutes after, the onset of each stress test.
|
Secondary Outcome(s)
|
1. Performance on affective go:no go, measured at rest (before first stress test) and 30 minutes after the start of each stress test 2. Ratio of negative to positive words correctly recalled, measured at rest (before first stress test) and 25 minutes after the start of each stress test 3. Which stress test leads to largest rise in cortisol?
|
Secondary ID(s)
|
7554; G0801443
|
Source(s) of Monetary Support
|
Medical Research Council (MRC) (UK) (ref: G0801443)
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|